Dermata Therapeutics Inc. (DRMA)
1.36
-0.08 (-5.56%)
At close: Jan 15, 2025, 2:24 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a | 322.00 | 1.35K |
| Gross Profit | n/a | n/a | n/a | -322 | -1.35K |
| Operating Income | -8.04M | -9.67M | -7.86M | -3.17M | -4.47M |
| Interest Income | 247.22K | 63.57K | 45.61 | 197.27 | 250.75 |
| Pretax Income | -7.79M | -9.61M | -7.90M | -3.24M | -4.72M |
| Net Income | -7.79M | -9.61M | -7.95M | -3.43M | -4.97M |
| Selling & General & Admin | 3.97M | 4.02M | 4.40M | 1.57M | 1.85M |
| Research & Development | 4.07M | 5.65M | 3.46M | 1.61M | 2.62M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 8.04M | 9.67M | 7.86M | 3.17M | 4.47M |
| Interest Expense | n/a | n/a | 45.61K | 197.27K | 250.75K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 8.04M | 9.67M | 7.86M | 3.17M | 4.47M |
| Income Tax | n/a | -9.67K | 45.61K | 197.27K | 250.75K |
| Shares Outstanding (Basic) | 194.00K | 690.67K | 520.54K | 520.54K | 520.54K |
| Shares Outstanding (Diluted) | 194.96K | 690.67K | 520.54K | 520.54K | 520.54K |
| EPS (Basic) | -40.18 | -13.92 | -15.27 | -6.6 | -9.55 |
| EPS (Diluted) | -39.98 | -13.92 | -15.27 | -6.6 | -9.55 |
| EBITDA | 247.22K | n/a | -7.86M | -3.17M | -4.47M |
| Depreciation & Amortization | 8.04M | 9.67M | 322.00 | 322.00 | 1.35K |